Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
34389857
DOI
10.1093/eurheartj/ehab342
PII: 6352178
Knihovny.cz E-zdroje
- Klíčová slova
- Observational studies, Primary percutaneous coronary intervention, Reperfusion therapy, ST-elevation myocardial infarction,
- MeSH
- infarkt myokardu s elevacemi ST úseků * terapie MeSH
- kardiologie * MeSH
- koronární angioplastika * MeSH
- lidé MeSH
- nemocnice MeSH
- prospektivní studie MeSH
- registrace MeSH
- reperfuze myokardu MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
AIMS: The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI). METHODS AND RESULTS: Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24 h in 196 centres across 29 countries. A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0-100%), fibrinolysis (18.8%; 0-100%), and no reperfusion therapy (9.0%; 0-75%) were performed. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.5-5.9%). Achievement of quality indicators for reperfusion was reported for 92.7% (region range 84.8-97.5%) for the performance of reperfusion therapy of all patients with STEMI <12 h and 54.4% (region range 37.1-70.1%) for timely reperfusion. CONCLUSIONS: The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality.
Aalborg University Hospital Department of Cardiology Hobrovej 18 22 9100 Aalborg Denmark
Ain shams University Ramsis Street Abbassia Square Cairo Egypt
Centro Hospitalar e Universitário do Algarve R Leao Penedo 8000 386 Faro Portugal
Hôpital Européen Georges Pompidou Service de Cardiologie 20 Rue Leblanc 75015 Paris France
Hospital Rudolfstiftung Juchgasse 25 1030 Wien Austria
Interventional Cardiology Unit Annunziata Civil Hospital Via Migliori 1 87100 Cosenza Italy
Iraqi Scientific Council of Cardiology Baghdad Heart Center Medical City Baghdad Iraq
Kyrgyz State Medical Academy 92 Akhunbayev St Bishkek Kyrgyzstan
Maria Cecilia Hospital GVM Care and Research Via Corriera 1 48033 Cotignola RA Italy
Mater Dei Hospital Triq Dun Karm L Imsida MSD2090 Msida Malta
National Center of Cardiology and Internal Medicine Togolok Moldo Str 720040 Bishkek Kyrgyzstan
North Estonia Medical Centre J Sütiste tee 19 13419 Tallinn Estonia
Rabin Medical Center Zeev Jabotinsky St 39 Petah Tikva 49100 Israel
Satakunta Cental Hospital Sairaalantie 3 28500 Pori Finland
Spitalul Clinic de Urgenta Floreasca Calea Floreasca 8 București 014461 Romania
St Vincent's University Hospital Merrion Rd Dublin 4 D04 N2E0 Ireland
Teaching Hospital of J A Reiman Cardiocentre Prešov Jána Hollého 5898 14 081 81 Prešov Slovakia
Citace poskytuje Crossref.org